Abstract
Lymphomatoid granulomatosis is a rare lymphoproliferative disorder involving the lungs, skin and other organs. Advanced-stage disease does not tend to respond well to cytotoxic chemotherapy and is associated with a poor prognosis. We present a case of successful treatment of relapsed lymphomatoid granulomatosis with bexarotene, a novel retinoid agent.
| Original language | English |
|---|---|
| Pages (from-to) | 1544-1546 |
| Number of pages | 3 |
| Journal | Cancer Biology and Therapy |
| Volume | 7 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 2008 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Bexarotene
- Lymphomatoid granulomatosis
- Lymphoproliferative disease
- New drugs for lymphoma
- Novel therapeutics
- Retinoid
- T-cell lymphoma
Fingerprint
Dive into the research topics of 'Successful treatment of relapsed lymphomatoid granulomatosis with bexarotene'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver